The MIT Koch Institute Clinical Investigator program offers physician-scientists a unique opportunity to participate in cutting-edge cancer research while continuing their medical practice and provides Koch Institute researchers with a frontline view of challenges in cancer treatment. This roundtable discussion with past and present Clinical Investigators explores the relationship between laboratory benchwork and clinical translation and practice.
Featured Presenters:
Scott Floyd, MD, PhD
Gary Hock and Lyn Proctor Associate Professor of Radiation Oncology, Duke University
Assistant Research Professor in Pharmacology and Cancer Biology, Duke University Cancer Center
Salil Garg, MD, PhD
Charles W. (1955) and Jennifer C. Johnson Clinical Investigator, Koch Institute
Pathologist, Massachusetts General Hospital
Hojun Li, MD, PhD
Charles W. (1955) and Jennifer C. Johnson Clinical Investigator, Koch Institute
Attending Physician, Dana Farber/Boston Children’s Hospital Cancer and Blood Disorders Center
Alice Tsang Shaw, MD, PhD
Global Head of Translational Clinical Oncology, Novartis
Attending Physician, Center for Thoracic Cancers, Massachusetts General Hospital
Moderated by Michael B. Yaffe, MD, PhD, Director, KI Clinical Investigator Program, David H. Koch Professor of Science, Professor of Biology and Biological Engineering
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
